Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
UVSP
|
Jeffrey M Schweitzer
Chairman, President & CEO |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 1.31% |
$34,236
$28.53 p/Share
|
Sep 03
2024 |
WSBF
|
Ellen Syburg Bartel
Director |
SELL
Open market or private sale
|
Direct | 2,129 Reduced 12.43% |
$31,998
$15.03 p/Share
|
Sep 03
2024 |
WSBF
|
Ellen Syburg Bartel
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,129 Added 11.06% |
$27,144
$12.75 p/Share
|
Sep 03
2024 |
RVP
|
Thomas J Shaw
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct | 15,096 Added 0.1% |
$13,888
$0.92 p/Share
|
Sep 03
2024 |
SAM
|
Carolyn L. O'Boyle
Chief People Officer |
SELL
Open market or private sale
|
Direct | 63 Reduced 0.9% |
$17,318
$274.9 p/Share
|
Sep 03
2024 |
STAF
|
Alicia Barker
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 40.97% |
-
|
Sep 03
2024 |
STAF
|
Vincent J Cebula
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 41.6% |
-
|
Sep 03
2024 |
STAF
|
Brendan Flood
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 29.52% |
-
|
Sep 03
2024 |
STAF
|
Nicholas Florio
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 41.58% |
-
|
Sep 03
2024 |
STAF
|
Dimitri Villard
Director |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 41.58% |
-
|
Sep 03
2024 |
ALTR
|
Teresa A Harris
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 620 Added 2.76% |
-
|
Sep 03
2024 |
ALTR
|
Teresa A Harris
Director |
SELL
Open market or private sale
|
Direct | 620 Reduced 2.84% |
$55,614
$89.7 p/Share
|
Sep 03
2024 |
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 27,451 Reduced 74.74% |
$1,869,138
$68.09 p/Share
|
Sep 03
2024 |
ACLX
|
Christopher Heery
CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 27,451 Added 42.77% |
$292,078
$10.64 p/Share
|
Sep 03
2024 |
OCEL
|
Skycrest Holdings, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 9,000 Added 3.24% |
$19,800
$2.2 p/Share
|
Sep 03
2024 |
EWBC
|
Rudolph Estrada
Director |
BUY
Bona fide gift
|
Indirect | 125 Added 0.0% |
-
|
Sep 03
2024 |
EWBC
|
Rudolph Estrada
Director |
SELL
Bona fide gift
|
Direct | 125 Reduced 0.68% |
-
|
Sep 03
2024 |
SHEN
|
Leigh Ann Schultz |
BUY
Grant, award, or other acquisition
|
Direct | 44 Added 0.21% |
$665
$15.12 p/Share
|
Sep 03
2024 |
TCPC
|
Eric John Draut |
BUY
Open market or private purchase
|
Direct | 1,900 Added 3.31% |
$17,366
$9.14 p/Share
|
Sep 03
2024 |
EDSA
|
Pardeep Nijhawan
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,055 Added 2.31% |
-
|
Sep 03
2024 |
BAND
|
Daryl Raiford
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,350 Reduced 5.73% |
$73,819
$16.97 p/Share
|
Sep 03
2024 |
SHEN
|
Michael Anthony Rhymes |
BUY
Grant, award, or other acquisition
|
Direct | 33 Added 50.0% |
$498
$15.12 p/Share
|
Sep 03
2024 |
LWAY
|
Ludmila Smolyansky |
SELL
Open market or private sale
|
Indirect | 4,584 Reduced 0.0% |
$89,617
$19.55 p/Share
|
Sep 03
2024 |
GNUS
|
Anthony D Thomopoulos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,088 Added 7.56% |
$2,624
$0.85 p/Share
|
Sep 03
2024 |
SHEN
|
Kenneth L Quaglio |
BUY
Grant, award, or other acquisition
|
Direct | 41 Added 0.19% |
$619
$15.12 p/Share
|
Sep 03
2024 |
MPWR
|
Theodore Blegen
EVP and CFO |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 3.9% |
$2,261,225
$904.49 p/Share
|
Sep 03
2024 |
SHEN
|
Richard L Koontz Jr |
BUY
Grant, award, or other acquisition
|
Direct | 33 Added 0.06% |
$498
$15.12 p/Share
|
Sep 03
2024 |
SHEN
|
Tracy Fitzsimmons |
BUY
Grant, award, or other acquisition
|
Direct | 68 Added 0.17% |
$1,028
$15.12 p/Share
|
Sep 03
2024 |
SHEN
|
Thomas Beckett |
BUY
Grant, award, or other acquisition
|
Direct | 26 Added 0.15% |
$393
$15.12 p/Share
|
Sep 03
2024 |
BIRD
|
Ann Mitchell
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 17,519 Reduced 2.13% |
$10,511
$0.6 p/Share
|
Sep 03
2024 |
EW
|
Catherine M. Szyman
CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct | 5,530 Reduced 6.37% |
$386,878
$69.96 p/Share
|
Sep 03
2024 |
EW
|
Catherine M. Szyman
CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct | 10,910 Added 11.16% |
-
|
Sep 03
2024 |
BIRD
|
Joseph Vernachio
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 47,351 Reduced 5.16% |
$28,410
$0.6 p/Share
|
Sep 03
2024 |
SHEN
|
Victor Christopher Barnes |
BUY
Grant, award, or other acquisition
|
Direct | 67 Added 0.63% |
$1,013
$15.12 p/Share
|
Sep 03
2024 |
EPIX
|
Peter Virsik
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,082 Reduced 18.51% |
$12,554
$6.03 p/Share
|
Sep 03
2024 |
MVIS
|
Jeffrey A Herbst
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 16.16% |
-
|
Sep 03
2024 |
MVIS
|
Simon Biddiscombe
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 10.87% |
-
|
Sep 03
2024 |
MVIS
|
Brian V Turner
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 5.18% |
-
|
Sep 03
2024 |
MVIS
|
Mark Bradley Spitzer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 15.74% |
-
|
Sep 03
2024 |
MVIS
|
Peter Schabert
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 50.0% |
-
|
Sep 03
2024 |
MVIS
|
Robert Paul Carlile
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 8.22% |
-
|
Sep 03
2024 |
MVIS
|
Jada Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,113 Added 50.0% |
-
|
Sep 03
2024 |
VHNAU
|
Rohan Malhotra |
BUY
Open market or private purchase
|
Direct | 10 Added 0.0% |
$21
$2.13 p/Share
|
Sep 03
2024 |
MSFT
|
Takeshi Numoto
EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,320 Reduced 13.68% |
$3,470,604
$417.14 p/Share
|
Sep 03
2024 |
MSFT
|
Takeshi Numoto
EVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 14,552 Added 19.32% |
-
|
Sep 03
2024 |
MSFT
|
Bradford L Smith
Vice Chair and President |
SELL
Payment of exercise price or tax liability
|
Direct | 22,413 Reduced 3.69% |
$9,349,358
$417.14 p/Share
|
Sep 03
2024 |
MSFT
|
Bradford L Smith
Vice Chair and President |
BUY
Grant, award, or other acquisition
|
Direct | 40,448 Added 6.25% |
-
|
Sep 03
2024 |
MSFT
|
Christopher David Young
EVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct | 14,162 Reduced 11.22% |
$5,907,536
$417.14 p/Share
|
Sep 03
2024 |
MSFT
|
Christopher David Young
EVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct | 19,573 Added 13.43% |
-
|
Sep 03
2024 |
USPH
|
Kathleen A Gilmartin |
BUY
Open market or private purchase
|
Direct | 2,000 Added 9.57% |
$172,180
$86.09 p/Share
|
Sep 03
2024 |